Brooks Automation Inc. (BRKS)
Barclays Capital Global Technology Conference Call
December 8, 2011 02:30 pm ET
Martin Headley - EVP & CFO
Well, good morning, ladies and gentlemen. Here to talk about Brooks Automation, the changes that we are going through leveraging our expertise for expansion into higher growth opportunities. The pathway for this will create a more diversified growth technology company. In doing so, there are a number of significant events that have occurred over the recent months. In June, we sold our Contract Manufacturing business to Celestica for a price of $80 million. This enables us to focus on higher technology development, higher margin companies. In furtherance of our Life Science Systems strategy, we acquired two leading automation sample management companies. And further, we have put in place higher research and development spend with a focus on markets that are adjacent to semiconductor wafer frontend.
If you look at the company as a whole, it is by no means clear with all these changes from the financials exactly what we have as a company, so I point out that if you take the pieces of the company that we now have, they have a trailing-12 months revenues of $580 million with gross margins of 37% to 38%.
But Brooks business today is represented in our fourth quarter fiscal 2011 financials, we are a September fiscal yearend company is within three continuing segments. Our Global Services Business which is primarily with foundries and fabs who have in place our equipment that we've sold through OEMs. It was about 17% of our business. Even though we only had the Life Sciences Business of Nexus for a part of the quarter that represented 7% of our revenues in the quarter.